cronos group glp-1 receptor agonist weight management diabetes treatments Healthy loss maintenance with exercise, agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial Advances in GLP-1 receptor agonists
Description
Secondary outcomes were each of these events considered separately
And for good reason, the science behind them is solid, and the results can be dramatic
Doctors warn against the move
In our newly released white paper, From Managing Illness to Building Health, we outline why fragmented, condition-specific approaches are no longer aligned with clinical science or financial outcomes and what a more integrated, prevention-focused model looks like in practice
The analysis spanned data from January 1, 2015, to December 31, 2023
